作者
Oren Ledder,Peter Church,Ruth Cytter-Kuint,María I. Martínez-León,Małgorzata Sładek,Eva Coppenrath,Batia Weiss,Baruch Yerushalmi,Javier Martín de Carpi,Larisa Duchano,Alexander J. Towbin,Amit Assa,Ron Shaoul,M. L. Mearin,George Alex,Anne M. Griffiths,Dan Turner,Tom Walters,Mary‐Louise C. Greer,David Mack,Eric I. Benchimol,Jorge Dávila,Tony Otley,Kathy O’Brien,Jeff Hyams,Doug Moote,Bob Baldassano,Judith R. Kelsen,Sudha A. Anupindi,Shehzad Saeed,Ted Denson,Daniel A. Lemberg,Jared Silverstein,Neal S. Leleiko,David Grand,Lucía Riaza,Víctor Navas,Frank M. Ruemmele,Laureline Berteloo,Raanan Shamir,Izabela Herman‐Sucharska,Lissy de Ridder,Jessie M. Hulst,Maarten H. Lequin,Martin N.J.M. Wasser,Richard K. Russell,Johanna C. Escher,Emily Stenhouse,Sibylle Koletzko,Michal Marianne Amitai,Osnat Konen,Anat Ilivitzki,Elhamy Bekhit,Daniel Moses
摘要
There is no standardized endoscopic description of upper gastrointestinal [UGI] disease in Crohn's disease [CD]. We prospectively applied the Simple Endoscopic Score for CD [SES-CD] to the UGI tract as a planned sub-study of the multicentre prospective ImageKids study. We aimed to assess the utility of the UGI-SES-CD and its clinical significance in paediatric CD.Patients underwent an oesophagogastroduodenoscopy [EGD], ileocolonoscopy, and magnetic resonance enterography [MRE] with explicit clinical data recorded. SES-CD was scored at each region [oesophagus, stomach body, antrum, and duodenum]. Half of the patients were followed for 18 months, when a repeat MRE was performed.A total of 202 children were included 56% males, mean age 11.5 ± 3.2 years, median weighted Paediatric Crohn's Disease Activity Index [wPCDAI 25]). UGI-SES-CD score ranged 0-17, with 95 [47%] having a UGI-SES-CD ≥1; no narrowing was detected. UGI-SES-CD ≥1 was associated with higher: wPCDAI [32.5 vs 20; p = 0.03]; Physician's Global Assessment [PGA] of inflammation (45 mm visual analogue score [VAS] vs 30 mm VAS; p = 0.04); ileocolonoscopic SES-CD [10 vs 7; p = 0.004], faecal calprotectin [717 µg/g vs 654 µ/g; p= 0.046]; and radiological global assessment of damage by MRE [7 mm VAS vs 0; p = 0.04]. In all, 81 patients were followed for 18 months and no association was identified between initial UGI SES-CD and markers of disease course such as surgery, MRE assessment, or treatment escalation.UGI-SES-CD is an easily reported objective scoring system and is associated with a more severe disease phenotype but not with disease course.